MedPath

Effects of TEAS on Stress Response During Extubation of General Anesthesia in Elderly Patients

Not Applicable
Completed
Conditions
Stress
Interventions
Device: Placebo
Device: Hwato Electronic Acupuncture Treatment Instrument
Registration Number
NCT02533388
Lead Sponsor
Shengjing Hospital
Brief Summary

Elderly patients have an increased risk of stress responses during extubation after general anaesthesia for an elective supratentorial craniotomy. How to decrease the stress responses during extubation after general anaesthesia remains challenging for the anaesthesiologist. In this study, we aimed to investigate whether transcutaneous electrical acupoint stimulation (TEAS) might decrease the stress responses and improve the quality of recovery in the elderly patients who underwent elective supratentorial craniotomy under general anaesthesia.

Detailed Description

A total of 100 elderly patients scheduled for elective supratentorial craniotomy under propofol-remifentanil total intravenous anaesthesia were randomly divided to either TEAS group (received stimulation at LI4, PC6, LU7, LU5, LI18 and ST9 acupoints, 2/10Hz, 6-15 mA) or Sham group (received no stimulation). The primary outcomes were the haemodynamic parameters and plasma concentrations of epinephrine (E), norepinephrine (NE) and cortisol (Cor). The secondary outcomes were the consumption of remifentanil and propofol, the time from discontinuation of anesthetics to extubation and reorientation, extubation quality score, the quality of postoperative recovery and postoperative complications.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • ASA Ⅱ~Ⅲ
  • aged 60-70years
  • scheduled for elective supratentorial craniotomy under general anaesthesia
Read More
Exclusion Criteria
  • past or current history of cardiovascular and/or cerebrovascular diseases
  • diabetes
  • pre-existing liver, lung or kidney dysfunction
  • psychiatric disorders
  • potentially difficult airway
  • previous acupuncture treatment
  • infection at the stimulus sites
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Sham stimulationPlaceboSham stimulation only connected to the apparatus, but electronic stimulation was not applied.
Electrical acupoint stimulationHwato Electronic Acupuncture Treatment InstrumentElectrical acupoint stimulation at the Hegu (LI4), Neiguan (PC6), Lieque (LU7), Chize (LU5), Futu (LI18) and Renying (ST9) acupoints, Stimulus frequency was an alternate dense-disperse frequency of 2/10 Hz ( 2 Hz for 10 s and 10 Hz for 5 s). The optimal intensity ranged from 6-15 mA, which was adjusted to maintain a slight twitching of the regional muscles according to individual maximum tolerance.
Primary Outcome Measures
NameTimeMethod
Change in plasma concentrations of epinephrineBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

plasma concentrations of epinephrine was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Change in mean arterial blood pressureBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Mean arterial blood pressure was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Change in heart rateBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Heart rate was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Change in cortisolBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Cortisol was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Change in Non-invasive arterial blood pressureBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Non-invasive arterial blood pressure was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Change in norepinephrineBefore the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Norepinephrine was recorded before the onset of TEAS,prior to induction, at the end of surgery, immediately after extubation, and 5 and 10 min after extubation

Secondary Outcome Measures
NameTimeMethod
The total amount of propofol that used throughout the surgeryFrom discontinuation of anaesthetic drugs to 24 h after surgery
Postoperative quality of recovery assessed by Quality of Recovery-40 questionnaire(QoR-40)From discontinuation of anaesthetic drugs to 24 h after surgery
the time to extubation,the time to reorientationFrom discontinuation of anaesthetic drugs to 24 h after surgery
The total amount of remifentanil that used throughout the surgeryFrom discontinuation of anaesthetic drugs to 24 h after surgery
the quality of extubation was evaluated by a 5-point Extubation Quality ScoreFrom discontinuation of anaesthetic drugs to 24 h after surgery
Postoperative complications,like cough,agitation,nausea and vomitingFrom discontinuation of anaesthetic drugs to 24 h after surgery

Cough was assessed using a four-point scale;Agitation was evaluated using the Ricker Sedation-Agitation Scale;Nausea was defined as the patient complained of an unpleasant sensation with the urgency to vomit. Vomiting was defined as the forceful expulsion of gastric contents from the patient's mouth.

Trial Locations

Locations (1)

Shengjing hospital of China medical university

🇨🇳

Shenyang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath